BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28035977)

  • 1. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
    Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
    Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
    Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.
    Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C
    Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.
    Shu XH; Li H; Sun XX; Wang Q; Sun Z; Wu ML; Chen XY; Li C; Kong QY; Liu J
    PLoS One; 2011; 6(11):e27484. PubMed ID: 22096581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.
    Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J
    Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of STAT3 NH
    Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
    Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
    Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
    Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
    Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
    Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoexpression analysis of selected JAK/STAT pathway molecules in patients with non- small-cell lung cancer.
    Pastuszak-Lewandoska D; Domańska-Senderowska D; Kordiak J; Antczak A; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Kiszałkiewicz JM; Brzeziańska-Lasota E
    Pol Arch Intern Med; 2017 Nov; 127(11):758-764. PubMed ID: 28972958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
    Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
    Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
    Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
    Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation.
    Wu M; Song D; Li H; Ahmad N; Xu H; Yang X; Wang Q; Cheng X; Deng S; Shu X
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
    Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
    J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.
    Jiao J; Zhang R; Li Z; Yin Y; Fang X; Ding X; Cai Y; Yang S; Mu H; Zong D; Chen Y; Zhang Y; Zou J; Shao J; Huang Z
    Nat Commun; 2018 Jun; 9(1):2504. PubMed ID: 29950561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation.
    Wen S; Li H; Wu ML; Fan SH; Wang Q; Shu XH; Kong QY; Chen XY; Liu J
    J Neurooncol; 2011 Aug; 104(1):169-77. PubMed ID: 21161674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
    Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
    Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.